Phase II study of idarubicin in advanced endometrial carcinoma.
Hakes
T B
TB
Raymond
V
V
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin; D007970:Leukopenia / Q000139:chemically induced; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D015255:Idarubicin; D003630:Daunorubicin